Kraig Biocraft Laboratories, Inc. announced that it has achieved full capacity at its current production location. Hitting this milestone was part of Kraig Labs' expansion plans for the first half of 2024. The Company now reports that it is moving forward with its planned investment into additional production facilities.

Kraig Labs began planning for this factory expansion during the spring trials after witnessing the strong growth and robustness of its new spider silk hybrids. This expansion is scheduled to take place in two waves. The first will address the near-term need for capacity during the upcoming rainy seasons, this will provide the needed secure space for production over the next several months.

The second, larger project will address Kraig Labs' longer-term need for hatchery space, which is expected to address production needs for the next 12-18 months. Permitting for both of these projects has been approved and the Company is now moving forward with investment into both of these expansion projects. Construction for both investments has begun, with the first project expected to be completed within just a few weeks and the larger effort is scheduled to be completed by early fall.

The Company expects to begin the third wave of recombinant spider silk production this month, focusing on scaling up the output of the parental lines for its production hybrids.